CZ2002707A3 - Pouľití mesoprogestinů (modulátorů receptoru pro progesteron) jako sloľky pro výrobu ľenských kontraceptiv - Google Patents

Pouľití mesoprogestinů (modulátorů receptoru pro progesteron) jako sloľky pro výrobu ľenských kontraceptiv Download PDF

Info

Publication number
CZ2002707A3
CZ2002707A3 CZ2002707A CZ2002707A CZ2002707A3 CZ 2002707 A3 CZ2002707 A3 CZ 2002707A3 CZ 2002707 A CZ2002707 A CZ 2002707A CZ 2002707 A CZ2002707 A CZ 2002707A CZ 2002707 A3 CZ2002707 A3 CZ 2002707A3
Authority
CZ
Czechia
Prior art keywords
mesoprogestin
estrogen
mesoprogestins
dosage forms
pharmaceutical composition
Prior art date
Application number
CZ2002707A
Other languages
Czech (cs)
English (en)
Inventor
Kristof Chwalisz
Walter Elger
Gerd Schubert
Original Assignee
Jenapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh & Co. Kg filed Critical Jenapharm Gmbh & Co. Kg
Publication of CZ2002707A3 publication Critical patent/CZ2002707A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
CZ2002707A 1999-08-31 2000-08-31 Pouľití mesoprogestinů (modulátorů receptoru pro progesteron) jako sloľky pro výrobu ľenských kontraceptiv CZ2002707A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
CZ2002707A3 true CZ2002707A3 (cs) 2002-11-13

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2002707A CZ2002707A3 (cs) 1999-08-31 2000-08-31 Pouľití mesoprogestinů (modulátorů receptoru pro progesteron) jako sloľky pro výrobu ľenských kontraceptiv

Country Status (28)

Country Link
EP (1) EP1605949A2 (xx)
JP (1) JP2003511399A (xx)
KR (1) KR20020038745A (xx)
CN (1) CN1384748A (xx)
AR (1) AR025455A1 (xx)
AU (1) AU781835B2 (xx)
BG (1) BG106441A (xx)
BR (1) BR0013711A (xx)
CA (1) CA2383650A1 (xx)
CO (1) CO5190694A1 (xx)
CZ (1) CZ2002707A3 (xx)
EA (1) EA006805B1 (xx)
EE (1) EE200200103A (xx)
HR (1) HRP20020265A2 (xx)
HU (1) HUP0202515A3 (xx)
IL (1) IL148415A0 (xx)
LT (1) LT5001B (xx)
LV (1) LV12940B (xx)
MX (1) MXPA02002186A (xx)
NO (1) NO20020998L (xx)
NZ (1) NZ517470A (xx)
PE (1) PE20010579A1 (xx)
PL (1) PL353994A1 (xx)
SI (1) SI20853A (xx)
SK (1) SK2982002A3 (xx)
UA (1) UA77150C2 (xx)
WO (1) WO2001026603A2 (xx)
YU (1) YU13902A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2273061T3 (es) * 2002-08-02 2007-05-01 Schering Aktiengesellschaft Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal.
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
JP2006525358A (ja) * 2003-05-02 2006-11-09 ドゥラメド ファーマシューティカルズ， インコーポレイテッド 長期周期避妊養生法を利用するホルモン治療の方法
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
PA8638601A1 (es) * 2004-07-07 2006-07-03 Wyeth Corp Regimenes y kits de progestina ciclica
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
NZ595790A (en) * 2009-04-14 2013-11-29 Hra Pharma Lab Method for on-demand contraception
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DK174071B1 (da) * 1987-09-24 2002-05-21 Jencap Res Ltd Kontraceptivt præparat i form af en pakning omfattende enhedsdoser
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4447715C2 (de) 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Behandlung von Prostatakarzinomen
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
ZA959008B (en) * 1994-10-24 1996-09-16 Schering Ag Competitive progesterone antagonists for demand-oriented female birth control
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
CZ290697B6 (cs) * 1996-06-25 2002-09-11 Akzo Nobel N. V. Systém pro perorální antikoncepci
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CN1353717A (zh) * 1999-05-04 2002-06-12 莱加制药公司 四环黄体酮受体调节剂化合物及其方法

Also Published As

Publication number Publication date
UA77150C2 (en) 2006-11-15
LV12940B (en) 2003-06-20
AU3215001A (en) 2001-04-23
WO2001026603A3 (en) 2002-01-17
EA006805B1 (ru) 2006-04-28
NZ517470A (en) 2004-03-26
BG106441A (bg) 2002-09-30
CA2383650A1 (en) 2001-04-19
HUP0202515A3 (en) 2004-06-28
CO5190694A1 (es) 2002-08-29
SK2982002A3 (en) 2002-07-02
YU13902A (sh) 2006-01-16
BR0013711A (pt) 2002-05-07
MXPA02002186A (es) 2002-09-02
PE20010579A1 (es) 2001-06-04
EA200200284A1 (ru) 2002-10-31
JP2003511399A (ja) 2003-03-25
WO2001026603A2 (en) 2001-04-19
SI20853A (sl) 2002-10-31
KR20020038745A (ko) 2002-05-23
PL353994A1 (en) 2003-12-15
CN1384748A (zh) 2002-12-11
AR025455A1 (es) 2002-11-27
AU781835B2 (en) 2005-06-16
HUP0202515A2 (hu) 2002-12-28
EE200200103A (et) 2003-04-15
EP1605949A2 (en) 2005-12-21
NO20020998D0 (no) 2002-02-28
LT2002035A (lt) 2002-10-25
LT5001B (lt) 2003-03-25
IL148415A0 (en) 2002-09-12
NO20020998L (no) 2002-03-14
HRP20020265A2 (en) 2004-02-29

Similar Documents

Publication Publication Date Title
SK78997A3 (en) Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
CZ292177B6 (cs) Antagonisty progesteronu a gestageny pro ošetření endometriózy a leiomyomata uteri
US6143754A (en) Competitive progesterone antagonist for demand-oriented female birth control
US20050064031A1 (en) Combination contraceptive, kits that contain the latter, and a method that uses the latter
CZ2002707A3 (cs) Pouľití mesoprogestinů (modulátorů receptoru pro progesteron) jako sloľky pro výrobu ľenských kontraceptiv
WO2021260511A1 (en) Multiphasic contraceptive and/or hormone replacement therapy
KR100729311B1 (ko) 호르몬 대체 요법(ｈｒｔ)용 조성물의 성분으로서의메조프로게스틴 (프로게스테론 수용체 조절물질)
HU221162B1 (en) Use of antiprogestin for preparing pharmaceutical compositions preventing or inhibiting the fertilization
ZA200201614B (en) Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives.
US7629334B1 (en) Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)